Scientific evidence classification · Phase 6A preserved + Phase 6B additions
PWWP Compounds
& Bioactivity
Explore experimentally studied preparations separately from deposited research ligands, buffers, ions and unresolved chemical evidence. Every role is source- and target-context specific.
Combined Phase 6A + Phase 6B denominators. These groups overlap; the 109 structurally source-tagged research ligands are unchanged. Deposited components and reagents are not automatically biochemical binders.
Evidence classification · exact source records
28 matching profiles
41 matching assay / association observations. Counts here are profiles, not unique assay events or deposited ligand instances; views overlap.
Measurements remain attached to the reported preparation.
compound 1 (de Freitas 2021)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 11 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 12 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 13 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 5 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 6 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
H4K20me3 peptide / trimethyllysine monomer
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
HS13
Source verification is pending.
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
MS9715N
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
NbH10
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
UNC7753
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
UNC8269
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
UNC8325
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
UNC8587
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
UNC8884
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
Source SMILES and full InChIKey require reconciliation.
(1R)-N-methyl-1-(pyridin-4-yl)propan-1-amine
Source verification is pending.
Source SMILES and full InChIKey require reconciliation.
(2R)-1-(cyclohexylamino)propan-2-ol
Source verification is pending.
Source SMILES and full InChIKey require reconciliation.
(2S)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)oxolane-2-carboxamide
Source verification is pending.
Source SMILES and full InChIKey require reconciliation.
(3R)-N-methyl-1-(pyridazin-3-yl)piperidin-3-amine
Source verification is pending.
Source SMILES and full InChIKey require reconciliation.
2-[(2S)-2-methylpiperidin-1-yl]ethan-1-amine
Source verification is pending.
Source SMILES and full InChIKey require reconciliation.
4-[[cyclopropyl-[(~{Z})-2-methyl-4-(5-oxidanylidene-2~{H}-1,4-oxazin-3-yl)but-3-enoyl]amino]methyl]-~{N}-[3-[2-[[4-(hydroxymethyl)phenyl]carbonyl-methyl-amino]ethyl]phenyl]benzamide
Source verification is pending.
Source SMILES and full InChIKey require reconciliation.
[(3S)-1-(propan-2-yl)piperidin-3-yl]methanol
Source verification is pending.
CYSTEINESULFONIC ACID
No source-curated measured assay in this context. Structural evidence is shown separately.
N-TRIMETHYLLYSINE
No source-curated measured assay in this context. Structural evidence is shown separately.
Measurements remain attached to the reported preparation.
UNKNOWN ATOM OR ION
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
Unknown ligand
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
ZINC ION
No source-curated measured assay in this context. Structural evidence is shown separately.